After FSL acquisition, patients experienced an A1c decrease of 1.5 1.9% ( p 10% had the largest reduction ( n = 497, 2.7 2.2%, p 24 months before FSL acquisition also showed improvements in A1c ( n = 478
The platform guides users through a simple online intake process, including a virtual consultation with a licensed physician and medication delivery straight to your door
Once released, GLP-1 enhances insulin secretion from pancreatic beta cells (in a glucose-dependent manner) and improves postprandial glucose control while suppressing glucagon release to prevent unnecessary glucose production
This conversion occurs through 5-reductase activity in hair follicles, creating localised hormonal environments that miniaturise follicles in genetically susceptible individuals
Federation WO (2022) London: World Obesity Federation
Novel dual agonists for GLP-1/glucagon and GLP-1/GIP are being developed by the pharmaceutical industry and have demonstrated some promising results for weight loss and improvement in glycaemia over and above GLP-1 analogues